Founded In 2018Surface Ophthalmicssurfacestands As A Pioneering Biopharmaceutical Firm Devoted To The Discovery And Market Introduction Of Advanced Treatments For Diseases Affecting The Ocular Surfaceour Mission Is To Address Critical Care Needs Within Eye Care By Harnessing In Depth Knowledgea Dynamic Strategya Focus On Efficiencyand Distinctive Clinical Benefitssurface Boasts A Remarkable Team Of Leaders And Advisorseach Distinguished By Their Outstanding Leadership Qualitiesexceptional Skillsand Comprehensive Industry Knowledgeae Factors That Are Vital To The Company S Achievements
